These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3694818)

  • 1. [Regulation of blood coagulation by heparin and related proteins].
    Takahashi K; Niwa M; Yamagishi R; Sakuragawa N
    Rinsho Ketsueki; 1987 Jul; 28(7):1094-101. PubMed ID: 3694818
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibitors of the serine-proteases of coagulation with special reference to antithrombin III and heparin cofactor II].
    Fontcuberta J
    Sangre (Barc); 1985; 30(4-C):787-91. PubMed ID: 3841417
    [No Abstract]   [Full Text] [Related]  

  • 3. [Glycosaminoglycans and inhibitors (antithrombin III and heparin cofactor II)].
    Sakuragawa N
    Nihon Rinsho; 1989 Apr; 47(4):759-65. PubMed ID: 2746884
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Inhibition mechanism of blood coagulation--especially on the function of antithrombin III].
    Sakuragawa N
    Rinsho Byori; 1985 Sep; 33(9):974-81. PubMed ID: 3841167
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serpin family proteins in blood coagulation and fibrinolysis (AT III, HC II, PCI, PAI-1, C1INA)].
    Suzuki K
    Nihon Rinsho; 1989 Apr; 47(4):805-15. PubMed ID: 2545944
    [No Abstract]   [Full Text] [Related]  

  • 6. The natural anticoagulants.
    Salem HH
    Clin Haematol; 1986 May; 15(2):371-91. PubMed ID: 3015466
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet heparin-neutralizing activity (platelet factor 4).
    Klener P; Kubisz P
    Acta Univ Carol Med (Praha); 1978; 24(7-8):79-86. PubMed ID: 551730
    [No Abstract]   [Full Text] [Related]  

  • 8. Anticoagulant properties of the vascular endothelium.
    Bombeli T; Mueller M; Haeberli A
    Thromb Haemost; 1997 Mar; 77(3):408-23. PubMed ID: 9065986
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antithrombin III and heparin cofactor II].
    Kondo S; Niwa M
    Rinsho Byori; 1985 Feb; Spec No 61():106-13. PubMed ID: 3839027
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thrombosis].
    Córdova S; Dorantes-Mesa S; Pizzuto J; Ruiz-Argüelles G; Izaguirre-Avila RA
    Gac Med Mex; 1989; 125(7-8):181-201. PubMed ID: 2534481
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemostasis in the mouse (Mus musculus): a review.
    Tsakiris DA; Scudder L; Hodivala-Dilke K; Hynes RO; Coller BS
    Thromb Haemost; 1999 Feb; 81(2):177-88. PubMed ID: 10063988
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of the nature and dynamics of changes in hemostasis in myocardial infarct. I. Antithrombin III and endogenous heparin activities].
    Zapolska-Downar D; Borodin M; Gregorczyk J; Chełstowski K; Sprogis W
    Przegl Lek; 1988; 45(4):387-91. PubMed ID: 3212203
    [No Abstract]   [Full Text] [Related]  

  • 13. [The inhibitory effects of histidine-rich glycoprotein on the anticoagulant activity of heparin].
    Niwa M
    Nihon Ketsueki Gakkai Zasshi; 1988 Nov; 51(7):1130-7. PubMed ID: 3223216
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
    Bohner J; von Pape KW; Blaurock M
    Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin III- and heparin cofactor II-mediated anticoagulant and antiprotease actions of heparin and its synthetic analogues.
    Jeske W; Fareed J
    Semin Thromb Hemost; 1993; 19 Suppl 1():241-7. PubMed ID: 8362268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immuno turbidimetric assay of heparin cofactor II].
    Takahashi K; Yamagishi R; Sakuragawa N; Shimamoto M; Ohsawa T; Kita M
    Rinsho Byori; 1988 Aug; 36(8):947-51. PubMed ID: 3241422
    [No Abstract]   [Full Text] [Related]  

  • 17. [Heparin].
    Roszkowska W; Worowski K
    Postepy Hig Med Dosw; 1984; 38(1):73-124. PubMed ID: 6387687
    [No Abstract]   [Full Text] [Related]  

  • 18. Reliability of amidolytic assays for progressive antithrombin and heparin cofactor activities on capillary blood.
    Hurlet-Birk Jensen A; Maes E; Gillet C; Legrand-Monsieur A
    Thromb Haemost; 1980 Jun; 43(2):104-7. PubMed ID: 7455966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin cofactor II and other coagulation inhibitors.
    Duckert F
    Behring Inst Mitt; 1986 Feb; (79):9-11. PubMed ID: 3755039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
    Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.